89bio Inc (ETNB) Company Profile & Statistics

89bio Inc
ETNB
(Nasdaq - US)
N/A
8.62
-0.35 (-3.90%)
in:usd•As of: May 17, 2024 15:59 UTC -4
Open
9.03
High
9.03
Low
8.59

About 89bio Inc

CEO

Rohan Palekar

Headquarters

142 sansome street, second floor

san francisco, ca 94104, united states

Auditor

KPMG LLP

Employees

Share Holders

Website

www.89bio.com

Industry

pharmaceuticals major

Sector

health technology

Company Overview

89bio Inc. is clinical-stage biopharmaceutical company. It is focused on the development and commercialization of therapies for the treatment of liver and cardio-metabolic diseases. The company's lead product candidate, BIO89-100, is being developed for the treatment of nonalcoholic steatohepatitis. 89bio Inc. is headquartered in San Francisco.

89bio Inc Statistics

Valuation Measures

Market Capitalization ²	848.04M
Enterprise Value	556.67M
Enterprise Value/EBITDA (ttm)	-3.56
Price to Earnings Ratio (ttm)	N/A
Price to Book (mrq)	1.67
Price to Sales (ttm)	N/A
Price to Cash (ytd)	N/A

Profitability

Gross Margin (ttm)	0.00%
Operating Margin (ttm)	N/A
Profit Margin (ttm)	0.00%
Return on Equity (ttm)	-34.76%
Return on Invested Capital (ttm)	-33.07%
Return on Assets (ttm)	-31.05%

Income Statement

Revenue (ttm)	0.00
Revenue Per Share (ttm)	0.00
Gross Profit (ttm)	0.00
EBITDA (ttm)³	-156.52M
Net Income Avi to Common (ttm)	-142.19M
Diluted EPS (ttm)	-2.01

Share Statistics

Beta (5Y Monthly)	1.15
52-Week Change	-49.02%
S&P500 52-Week Change	26.33%
S&P500 Member	No
Stock Optionable	Yes
Total Shares Outstanding ¹	93.50M
Dividend Yield	0.00%
Float ⁴	95.63M
% Held by Insiders	2.80%
% Held by Institutions	N/A

Balance Sheet

Total Cash (mrq)	578.87M
Total Cash Per Share (mrq)	6.19
Total Debt (mrq)	24.80M
Total Debt/Equity (mrq)	4.89%
Current Ratio (mrq)	15.03%
Quick Ratio (mrq)	20.04%
Book Value Per Share (mrq)	5.36

Cash Flow

Operating Cash Flow Per Share (ytd)	-0.41
Free Cash Flow (ytd)	-39.72M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. Stock price provided by Xignite. All numbers are rounded to the closest decimal.

¹ Total Shares outstanding is taken from the most recently filed quarterly or annual report.

² Market Cap is calculated using total shares outstanding and the most recent share price.

³ EBITDA is calculated using methodology that may differ from that used by a company in its reporting.

⁴ The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.

89bio Inc

Trade With A Regulated Broker